XPG is a structure-specific endonuclease required for nucleotide excision repair (NER). XPG incision defects result in the cancer-prone syndrome xeroderma pigmentosum, whereas truncating mutations of XPG cause the severe postnatal progeroid developmental disorder Cockayne syndrome.
Introduction
The maintenance of genomic integrity is persistently threatened both by endogenous damage from the cellular metabolism and exogenous environmental sources such as UV and ionizing radiation and mutagenic chemicals. To counter this damage, organisms across the evolutionary scale are equipped with complex and interconnected DNA repair pathways that detect and remove lesions in DNA. XPG is a structure-specific endonuclease that cleaves DNA bubbles and flaps near the junctions of singlestranded and double-stranded DNA with specific polarity. 1, 2 It also binds strongly to various structured DNAs that it does not cleave, implying separate biological functions for its binding and incision activities. 2, 3 The incision activity of XPG is essential for removing bulky DNA adducts by the nucleotide excision repair (NER) pathway, 1 and point mutations that inactivate the XPG endonuclease function cause the cancer-prone, sun-sensitive disorder xeroderma pigmentosum (XP) in XP-G patients. 4, 5 XPG also has a non-enzymatic scaffolding role in several steps of NER, including coordination of incision with the resynthesis step. 6, 7 Regions of XPG share extensive sequence homology with flap endonuclease 1 (FEN1), a much smaller structure-specific endonuclease that removes RNA primers from Okazaki fragments. 8 In addition, XPG has unique regions with no homology to other known proteins, including an R-(recognition) domain (also called the spacer region) that is larger than the entire FEN1, plus a C-terminal domain that is significantly longer than the corresponding region in FEN1 (Fig. 3C) . 3, 9 The C-terminus contains a PCNA binding motif. 10 Separate from its required function in NER, XPG is essential for normal postnatal development in mammals. Patients with rare truncating mutations in XPG have the combined diseases of XP with
Cockayne syndrome (XP-G/CS). 5, [11] [12] [13] XP-G/CS presents as severe primarily postnatal neurological and developmental dysfunction with mental retardation, wasting, greatly accelerated symptoms of segmental aging, and death in early childhood. XPG knockout mice recapitulate this patient phenotype, exhibiting severe postnatal wasting and death before 3 weeks of age. 14 In contrast, mice that lack NER owing to point mutations that inactivate XPG enzymatic activity are normal except for UV sensitivity. 15, 16 Thus, loss of NER per se is evidently not responsible for the CS phenotypes that develop in mice and humans with severely truncating or null mutations of XPG. 15, 16 In particular, loss of the extended C-terminus of XPG has been implicated in the CS phenotype by knock-in mouse mutations. 16, 17 We and others have shown that XPG has multiple non-enzymatic functions that might contribute to the fatal postnatal phenotype associated with its loss. It has a role in the early steps of base excision repair (BER) of oxidative DNA damage through direct interaction with and stimulation of NTH1 [18] [19] [20] and other DNA glycosylases (A.H. Sarker et al, in preparation). Moreover, XPG interacts directly 3 with both RNA polymerase II and the CSB protein that is essential for initiation of transcription-coupled repair (TCR), a process that preferentially removes transcription-blocking lesions through recognition of stalled RNA polymerase. 21 Since oxidative damage to DNA is a principal source of endogenously generated lesions, and since inability to carry out TCR is the molecular hallmark of CS, loss of BER and/or TCR functions of XPG could contribute to the XP-G/CS phenotype. In addition, XPG forms a complex with the transcription and repair factor TFIIH and is important for stable association of the CAK kinase subunit with TFIIH, with the consequence that XP-G/CS cells are deficient in phosphorylating and activating nuclear receptors such as ERα. 22 Although these activities of XPG are likely important and therefore contribute to its postnatal requirement, the exact nature of the defect leading to XP-G/CS and very early death is still not clear. 23 WRN is a 3'-5' RECQ-like DNA helicase with a marked preference for substrates with extensive secondary structure. 24 It also possesses an opposing DNA annealing activity that, when coordinated with its helicase activity, is capable of performing strand exchange. 25 Alone among the RECQ helicases, WRN has an exonuclease domain 26 and 3'-5' exonuclease activity. 27 Additionally, WRN has been reported to stimulate BER, [28] [29] [30] [31] and it clearly plays a role in non-homologous endjoining (NHEJ) of DNA double-strand breaks (DSBs). [32] [33] [34] WRN localizes primarily to nucleoli, but in S-phase it moves from the nucleoli to stalled replication forks, evident as distinct nuclear foci that also contain RPA and RAD51. 35, 36 In addition, a fraction of WRN associates with telomeres during S-phase, where it is important for lagging strand synthesis in the replication of telomeric DNA. 37 Loss of WRN leads to increased chromosome aberrations, defective resolution of Holliday junctions, abnormal DNA replication intermediates, large deletions, and increased incidence of telomere sister chromatid exchange. [37] [38] [39] [40] [41] Direct measurement of replication fork kinetics showed that after DNA damage, replication fork progression was significantly slower in the absence of WRN. 42 Thus WRN clearly has an important, though poorly understood, role during replication, and it, like XPG, participates in multiple DNA transactions.
We here provide evidence that XPG interacts directly with WRN and co-localizes with it in nuclear foci in mid-to late-S-phase. We mapped the interaction to the C-terminus of both proteins and show that the C-terminus of XPG strongly stimulates WRN helicase activity, while possessing a previously unrecognized single-strand DNA annealing activity that functions cooperatively with WRN. These results suggest a novel role for XPG in S-phase either separately or together with WRN, and provide additional insight into the severe nature of the defects observed in XP-G/CS patients.
Results
XPG directly interacts with WRN, undergoes similar sub-nuclear redistribution in S-phase, and co-localizes with WRN in nuclear foci. To better understand the non-enzymatic role(s) of XPG and the basis for its postnatal requirement, we carried out a search to identify new XPG-interacting partner proteins in cells. We immunoprecipitated nuclear extracts of hTERT-immortalized normal human HCA2 fibroblasts with anti-XPG or control antibody and found that WRN coimmunoprecipitated with XPG. This interaction was evident in both asynchronous cells and cells in mid-S-phase (Fig. 1A) . To expand upon this observation, we sought other lines of evidence for an interaction of XPG and WRN, using both biochemical approaches and cellular immunofluorescence.
To understand how XPG and WRN respond to cell cycle position and DNA damage, we employed a serial biochemical fractionation protocol that extracts proteins in nine steps, separating them into soluble, chromatin and nuclear matrix fractions. 43 The nuclear matrix is a structural scaffold that anchors arrays of chromatin loops and plays an important role in replication, transcription, and most likely also DNA repair. 44 The fractions were analyzed by western blotting (Fig. 1B) , and successful fractionation was confirmed by the presence of histone H1 in the soluble fraction and vimentin in the nuclear matrix fraction (Supplemental Fig. 1 ).
In undamaged asynchronous cells, both WRN and XPG were largely in the soluble fraction (Fig. 1B , lane 1). After UV damage, a fraction of XPG moved to the chromatin (top, lanes 5-6). By analogy with other proteins, this presumably reflects its function in global NER. 45 Strikingly, XPG was also detected in the insoluble nuclear matrix fraction (top, lane 9), likely reflecting XPG function in TCR. 43 As expected for a protein not thought to be involved in NER or TCR, WRN did not leave the soluble fraction when asynchronous cells were damaged by UV (Fig. 1B, bottom) . However, in cells synchronized in S phase, a substantial fraction of WRN became bound to the chromatin and nuclear matrix at four hours after release from the G1/S boundary (S4), consistent with its known relocalization to replication forks. Unexpectedly, a significant amount of XPG protein also relocalized to chromatin during mid-S phase in undamaged cells, and a minor fraction was also detectable at the nuclear matrix.
When cells in S-phase were UV-irradiated, causing collapsed or stalled replication forks, even greater amounts of both XPG and WRN associated with the chromatin and nuclear matrix fractions. The similar behavior of the two proteins with respect to sub-nuclear redistribution in S-phase, and particularly in response to replication-blocking damage in S, is consistent with their observed interaction.
We next used indirect immunofluorescence microscopy to investigate the spatial localization of XPG relative to WRN in S-phase cells. To visualize only proteins bound to the chromatin or nuclear matrix, we permeabilized and gently washed the cells prior to fixation. 46 This step was critical to our ability to observe discrete foci containing XPG (Supplemental Fig XPG stimulates WRN helicase activity. To investigate whether the novel interaction between XPG and WRN has functional significance, we examined the effect of XPG on WRN helicase activity.
We first titrated WRN helicase activity (Supplemental Fig. 3 ) to determine a limiting amount of purified WRN protein, which we then tested in the absence or presence of varying concentrations of XPG.
Reactions were initiated by addition of WRN to a mixture of XPG and a partial duplex DNA substrate (Fig. 3A) . Unwound DNA products were separated from duplex DNA by gel electrophoresis. XPG substantially stimulated WRN unwinding activity in a concentration-dependent manner (Fig. 3A , lanes 6-10). As expected, there was no unwinding by XPG alone (Fig. 3A, lane 11; Fig. 3B ). Under these experimental conditions, WRN alone unwound 3% of the substrate, and XPG increased the unwinding by 6.5 fold (24.6% of substrate) (Fig. 3B) . Next, we examined the effect of XPG on the kinetics of WRN unwinding. Notably, presence of full-length XPG increased the rate of WRN unwinding >5-fold (Fig.   3C ).
Having shown that interaction of XPG with WRN is through the C-terminus of XPG, we used XPG proteins that lacked or contained the C-terminus (XPGΔC and MBP-C-term) to determine whether direct interaction between WRN and XPG is required for the stimulation of WRN unwinding activity. XPGΔC did not appreciably alter WRN helicase activity, whereas the XPG C-terminus alone stimulated unwinding, although only at a much higher concentration than full-length XPG (Fig. 3D) . Thus, the Cterminal domain of XPG is both necessary and sufficient for stimulation of WRN helicase activity, as it is for direct interaction of the two proteins.
XPG anneals ssDNA alone and cooperatively with WRN. RECQ helicases including WRN not only unwind duplex DNA but also catalyze the opposing activity of ssDNA annealing. Both properties may be important for replication fork regression and/or the re-start of stalled replication forks. To determine whether XPG also affects the annealing activity of WRN, we assayed for DNA strand annealing using a labeled ssDNA substrate and unlabeled complementary DNA oligonucleotide. Assays were performed in the absence of ATP to prevent helicase activity. We first used an amount of WRN that efficiently anneals DNA (Fig. 4A, lanes 2 and 3) and tested whether XPG inhibits annealing by WRN. However, addition of increasing concentrations of XPG to the reaction not only failed to inhibit annealing but appeared to stimulate it (Fig. 4A, lanes 4-8) . Very surprisingly, the XPG-only control reaction revealed that XPG itself possesses intrinsic ssDNA annealing (Fig. 4A, lane 9 ).
To examine this new function of XPG, we titrated either XPG or its smaller homolog FEN1 into the ssDNA annealing assay. XPG efficiently annealed DNA in a concentration dependent manner, whereas FEN1 completely lacked this activity ( Fig. 4B ; quantified in Fig. 4C ). Testing various XPG domain constructs ( Fig. 2A) showed that proteins lacking either the R-or C-terminal domains performed some
annealing, but at very low levels compared to the full-length protein (Fig. 4D) . The XFXΔC construct, which retains the endonuclease domain but lacks the R-and C-terminal domains (thus resembling FEN1), lacked annealing activity (indistinguishable from buffer alone) (Fig. 4D) . A catalytically inactive mutant XPG, XPGD77A, 48 was almost as competent as wt protein for annealing (Fig. 4D) . Thus both the R-and C-terminal domains, but not endonuclease activity, are important for this unexpected activity of XPG.
Having found that XPG interacts directly with WRN and possesses similar DNA annealing activity, we asked whether XPG and WRN annealing activities are additive or cooperative. We measured the DNA annealing activities of sub-stoichiometric concentrations of XPG and WRN separately and in combination at the same concentrations. Annealing by both proteins together was 140% greater than the sum of the individual reactions (Fig. 4E) . Thus, ssDNA annealing by XPG and WRN is cooperative.
These findings, together with the ability of XPG to stimulate WRN helicase activity, indicate functional significance for the direct interaction of XPG with WRN.
Discussion
We have identified a direct functional interaction between XPG and WRN proteins, revealed an unexpected strand annealing activity of XPG, and demonstrated that WRN and XPG both undergo similar sub-nuclear redistributions to foci in S-phase, Further, we found that XPG and WRN co-localize in nuclear foci specifically during mid-S-phase. Although XPG foci formed throughout S-phase, the colocalization was not observed until mid-to late-S-phase, when WRN moves from nucleoli to nuclear foci that contain markers of stalled replication forks such as RAD51 and RPA, as well as telomeric proteins and telomeric DNA. 37 The hypothesized function of WRN in S-phase nuclear foci is informed by the phenotype of cells (Fig. 5) . Recently, it was shown that WRN efficiently catalyzed regression even through RPA-bound ssDNA, resulting in RPA displacement. 51 Because XPG also physically interacts with RPA, 52 WRN, XPG, and RPA may function together to mediate the process of replication fork regression and/or fork restart (Fig. 5) . The absence of this pathway could lead to an increased incidence of replication fork breaks and might explain the increase in recombination events 34 and genomic instability observed in WS cells.
Multiple lines of evidence additionally support a role for WRN at telomeres. WRN foci not only colocalize with telomeric proteins, but WRN directly binds telomeric chromatin 37 and interacts directly with the shelterin proteins TRF2 and POT1, both of which stimulate its helicase activity. 53, 54 Further, WRN-deficient cells undergo rapid replicative senescence without accelerated telomere shortening but with aberrant telomeric structures, including increased telomere associations and telomere sister chromatid exchanges, and loss of the G-rich lagging strand DNA. 37, 41 These data suggest that telomere dysfunction is one cause of the observed genomic instability and premature aging observed in WS. It is possible that the interaction of XPG with WRN is functionally important in telomere maintenance, and so it will be of interest to learn whether XPG has a role at telomeres in S-phase. This novel possibility may partially explain the severe progeroid developmental disorder seen in XP-G/CS patients, although the early postnatal appearance of progeria is in marked contrast to the relatively late onset of WS symptoms.
WRN additionally has a role in the processing of DSBs, particularly in the NHEJ pathway. WS fibroblasts display a mild but distinct sensitivity to ionizing radiation, and WRN additionally interacts physically and functionally with DNA-PK, which phosphorylates WRN and stimulates WRN exonuclease activity. 32 Notably, WRN accumulates at sites of laser-induced DSBs, but not at singlestrand breaks or oxidative base damage. 55 Whereas the helicase and exonuclease domains were shown to be dispensable for WRN recruitment to DSBs, the annealing domain, which has been mapped to WRN residues 1072-1150, 56 was absolutely required for recruitment. 55 In this context, it is of particular significance that our mapping results show that one of the two XPG interaction domains in WRN is coincident with the annealing domain. Thus, it is possible that the interaction between XPG and WRN promotes WRN recruitment to this type of damage and regulates its activity at the break site.
The regulation and coordination of the multiple biochemical functions of WRN -DNA binding, unwinding, annealing, and exonuclease activities -and its multiple cellular functions are poorly understood. It is likely that protein partner interactions serve to both localize WRN to specific cellular sites and modulate its enzymatic activities. Several domains of WRN have been structurally characterized, including the unique N-terminal exonuclease domain, which is homologous to the E. coli DNA polymerase I proofreading domain, 26 the C-terminal HRDC domain, 57 which is important for substrate specificity, the RECQ C-terminal (RQC) domain (949-1079), 58 and a novel heptad repeat coiled-coil region between the nuclease and helicase domains that facilitates multimerization of WRN. 59 The RQC domain is particularly interesting, because it contains a novel winged-helix motif that contributes to base un-pairing, 58 and one of the two XPG interaction domains with WRN maps to WRN amino acids 1070-1142, immediately adjacent to the core RQC domain (Fig. 2C) . This region, which was recently shown to be necessary and sufficient for the intrinsic ssDNA annealing activity of WRN, is currently structurally uncharacterized. 56 The PONDR secondary structure prediction program 60 suggests that the domain is largely disordered. It is possible that the interaction between XPG and WRN may confer a disorder-to-order transition that serves to modulate WRN protein activity, as illustrated by their cooperative DNA strand annealing. Whether the interaction confers structure to an otherwise unstructured region will be an interesting hypothesis to test in future studies.
The direct, functional interaction of XPG with WRN suggests that XPG may participate in any one of the aforementioned critical pathways with WRN. However, it is important to note that the progeroid developmental phenotype seen in XP-G/CS patients is far more severe than the phenotypes observed with WS patients. This discrepancy implies that XPG functions in important cellular pathways independently from WRN. While the severity of the XP-G/CS phenotype likely results in part from the requirement for XPG in TCR and/or BER (Fig. 5) , it is additionally possible that XPG plays a role during S-phase independently of WRN. Notably, the XPG foci that form in S-phase do not entirely colocalize with WRN. We observed XPG foci both in early S-phase at a time when WRN is still predominantly nucleolar and in mid/late S-phase when a majority of cells contain WRN and/or XPG foci. At this time, however, only 10-15% of the cells showed substantial co-localization between XPG and WRN, although in those cells the degree of co-localization was nearly complete. These data strongly suggest that XPG functions with WRN at a particular stage in S-phase and that it also has other replication-associated functions, and likely other novel protein partners. Discerning these additional new functions of XPG should provide further clues to the extreme phenotype of patients lacking functional XPG. In addition, the demonstrated interaction between XPG and WRN in mid-to late S-phase opens the way for understanding the mechanisms by which genomic integrity is maintained during replication by interactions of the DNA repair pathways mediated by these two multi-functional proteins.
Materials and Methods
Cells and cell culture. HCA2 foreskin fibroblasts were from J. Smith (University of Texas, USA), and were immortalized by infection with an hTERT-expressing retrovirus as previously described 61 .
XPCS2LV fibroblasts (GM13370) were from the Coriell NIGMS Human Genetic Cell Repository. Cells were cultured under ambient oxygen levels and 10% CO 2 in DMEM supplemented with 10% fetal calf serum. Synchronization into G1 or S-phase was performed as previously described.
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Antibodies. The XPG antibodies used were mouse monoclonal anti-XPG 8H7 (Abcam or Neomarkers), which recognizes an epitope in the XPG C-terminal region, and polyclonal rabbit anti-XPG 97714, which we raised against a conserved R-domain peptide and purified as described. 3 Other antibodies used were rabbit anti-WRN (ab200, Abcam, for western analysis and immunofluorescence), 
Cellular fractionation into soluble, chromatin-bound, and nuclear matrix-associated proteins.
Cell lysates were fractionated by sequential extraction with salt and detergent essentially as previously described. 43, 63 Briefly, soluble proteins were extracted by a low concentration of non-ionic detergent (fractions 1, 2), then loosely bound chromatin proteins were released by DNase I (fraction 3). More tightly bound chromatin-associated proteins were progressively released by increasing salt concentrations (fractions 4-7), ending with high salt containing 1% Triton X-100 (fraction 8). Proteins associated with the insoluble nuclear matrix were released by 2-4% SDS (fraction 9).
Indirect Immunofluorescence. For XPG immunostaining, cells in 4 or 8-well chamber slides (Invitrogen) were permeabilized with 0.5% Triton in CSK buffer 63 and then fixed with 4%
paraformaldehyde. For 53BP1 immunostaining alone, cells were fixed with 4% paraformaldehyde and then permeabilized with 0.5% Triton in CSK buffer. Samples were blocked with 10% goat serum prior to incubating overnight at 4° C with primary antibody in 10% serum. Following washes with PBS, we incubated samples with conjugated secondary antibodies for 30 min at room temperature, followed by 3 washes with PBS. The final wash contained DAPI (0.1mg/ml). We mounted slides in Vectashield and viewed by epifluorescence. Images of cells were acquired on a microscope (BX60; Olympus) using a 40x UPlanFl 0.5 NA (Olympus) lens without oil and captured with a charge-coupled device camera (Diagnostic Instruments, Inc.) into SPOT imaging software (Diagnostic Instruments, Inc.). All modifications were applied to the whole image using Photoshop CS2 (Adobe).
Expression and purification of proteins. Full-length WRN, XPG, and XPG constructs XPGΔC, XFX, XFXΔC and XPG D77A were expressed in insect cells and purified essentially as described. 3, 27 For creation of fusion constructs with Maltose Binding Protein (MBP), R-domain (XPG residues 86-765) and C-term domain (XPG residues 1007 to 1186) segments were cloned into pGAZ/MBP1 (kind gift of Gareth Williams, LBNL) containing 6-His and MBP tags upstream of the XPG sequence. The domain fusion constructs and 6-His-MBP without XPG sequences were expressed and purified from E.
coli by a combination of nickel affinity, ion exchange and gel-filtration chromatography. The WRN exonuclease construct (1-333) was expressed and purified as previously described. 26 The Nuclear extraction and immunoprecipitation. Cells were washed in five cell pellet volumes (CPV) with ice cold hypotonic buffer (Buffer A) containing 10 mM Tris, pH 7.9, 1.5 mM MgCl 2 , 5 mM KCl, 0.5 mM DTT, 0.1 mM PMSF and protease inhibitors, followed by centrifugation at 250 g. Cell pellets were resuspended in three CPV Buffer A and dounce homogenized. Nuclei were collected by centrifugation at 250 g, and resuspended in 50 mM Tris, pH 7.9, 2 mM EDTA, 10% sucrose, 10% glycerol, 0.1 mM PMSF and protease inhibitors. NaCl was added to a final concentration of 300 mM, followed by incubation on ice for 30 min, and centrifugation at 1000 g. The nuclear extracts (supernatant) were diluted to 150 mM NaCl prior to immunoprecipitation. Extracts were precleared with mouse IgG prior to addition of XPG antibody or control mouse IgG.
Far western analysis. Far westerns were performed as previously described. in which no XPG protein is detectable by western analysis, were synchronized in mid S-phase and immunostained with rabbit anti-XPG 97714 (red). Nuclei were stained blue with DAPI.
